Exhibit 31.1

                           CERTIFICATION OF PRESIDENT
                PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,
                             RULES 13A-14 AND 15D-14
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of  PracticeXpert,  Inc. (the "Company")
on Form 10-QSB for the period ending June 30, 2004 as filed with the  Securities
and Exchange  Commission on the date hereof (the "Report"),  I, Jonathan Doctor,
President  of the Company,  certify,  pursuant to Rules 13a-14 and 15-d14 of the
Securities  Exchange Act of 1934 (the "Exchange  Act"),  as adopted  pursuant to
ss.302 of the Sarbanes-Oxley Act of 2002, that:

1.    I have reviewed this Report;

2.    Based on my knowledge,  this Report does not contain any untrue  statement
      of a material fact or omit to state a material fact  necessary to make the
      statements made, in light of the circumstances under which such statements
      were made,  not  misleading  with  respect  to the period  covered by this
      Report;

3.    Based on my  knowledge,  the  financial  statements,  and other  financial
      information  included  in this  Report,  fairly  present  in all  material
      respects the financial condition,  results of operations and cash flows of
      the Company, as of, and for, the periods presented in this Report;

4.    I and the other  certifying  officers of the Company are  responsible  for
      establishing  and  maintaining  disclosure  controls  and  procedures  (as
      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and
      have:

      (a)   Designed such  disclosure  controls and  procedures,  or caused such
            disclosure   controls  and  procedures  to  be  designed  under  our
            supervision,  to ensure that  material  information  relating to the
            Company, including any consolidated  subsidiaries,  is made known to
            us by others within those entities,  particularly  during the period
            in which this Report is being prepared;

      (b)   Evaluated the effectiveness of the Company's disclosure controls and
            procedures  and presented in this Report our  conclusions  about the
            effectiveness of the disclosure  controls and procedures,  as of the
            end of the period  covered by this Report based on such  evaluation;
            and

      (c)   Disclosed  in this  Report  any  change  in the  Company's  internal
            control over financial  reporting that occurred during the Company's
            most recent fiscal quarter (the  Company's  fourth fiscal quarter in
            the case of an annual  report) that has materially  affected,  or is
            reasonably  likely to  materially  affect,  the  Company's  internal
            control over financial reporting; and

<PAGE>

5.    I and the other  certifying  officers  have  disclosed,  based on our most
      recent  evaluation of internal  control over financial  reporting,  to the
      Company's  auditors and to the audit  committee of the Company's  board of
      directors (or persons performing the equivalent functions):

      (a)   All significant  deficiencies and material  weaknesses in the design
            or operation of internal control over financial  reporting which are
            reasonably  likely to  adversely  affect  the  Company's  ability to
            record, process, summarize and report financial information; and

      (b)   Any fraud,  whether or not  material,  that  involves  management or
            other  employees  who  have a  significant  role  in  the  Company's
            internal control over financial reporting.


/s/ Jonathan Doctor
-----------------------
Jonathan Doctor,
Chief Executive Officer
August 23, 2004